SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-20-001258
Filing Date
2020-10-07
Accepted
2020-10-07 19:42:29
Documents
2
Period of Report
2020-10-04

Document Format Files

Seq Description Document Type Size
1 e619991_3-camilla.html 3  
1 e619991_3-camilla.xml 3 1617
2 e619991_ex24.htm EX-24 7238
  Complete submission text file 0001193805-20-001258.txt   10384
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Graham Camilla (Reporting) CIK: 0001827543 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 201229889